Health and Healthcare

All Health and Healthcare Articles

Newest first · Page 142

Why Solid Biosciences Is Under Fire From the FDA

Solid Biosciences Inc. (NASDAQ: SLDB) watched its shares get crushed on Thursday after the company announced some complications with the U.S. Food and Drug Administration (FDA). Specifically, the FDA notified the firm that its…

Chris Lange · 9 years ago

Bellicum Bounces With Cancer Drug Data

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares made a solid gain on Tuesday after the company announced interim clinical data of BPX-501 in pediatric patients with acute myeloid leukemia (AML) and primary immunodeficiencies (PIDs).

Chris Lange · 9 years ago

Is Anthera Dead in the Water?

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) saw its shares get absolutely crushed in Monday’s session following missed results in a late-stage study. Specifically, the company said that Sollpura did not meet the non-inferiority margin of…

Chris Lange · 9 years ago

Major Biotechs: Tough Call for Short Sellers

The February 28 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.

Chris Lange · 9 years ago

Major Pharma Sees Big Drop in Short Interest

The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.

Chris Lange · 9 years ago

Why Vascular Biogenics Is Getting Crushed

Vascular Biogenics watched its shares get absolutely crushed on Thursday after the firm reported top-line results for its late-stage trial in patients with recurrent glioblastoma.

Chris Lange · 9 years ago

Is It Finally Time to Buy Into Mylan?

Mylan has been through the ringer over the past couple of years, but by the looks of it, this stock could be turning around.

Chris Lange · 9 years ago